|
A purposeful or accidental release of a biological agent (e.g. Anthrax, or Smallpox) that poses a public health threat
22 Resources
324
Centers for Disease Control and Prevention
Laboratory Response Network, . "Level A Laboratory Guidelines for Identification of Clostridium botulinum Toxin" [Guidelines/protocol], 2003-05-03 (PDF; 149k)
http://www.bt.cdc.gov/agent/botulism/botulismlabprotocol.pdf
Outlines protocol for collecting samples as well as transporting to lab
Botulism--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
250
Centers for Disease Control and Prevention. Emerging Infectious Diseases
Dworkin, M.S.. "Fear of Bioterrorism and implications for Public Health Preparedness" [Article (research)], 2003-04-01 (HTML; 52k)
http://www.cdc.gov/ncidod/EID/vol9no4/02-0593.htm
study of 2001 anthrax samples in Illinois
Anthrax--Preparedness--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Evaluation
315
Centers for Disease Control and Prevention
Laboratory Response Network, . "Level A Laboratory Procedures for Identification of Bacillus anthracis" [Guidelines/protocol], 2003-03-24 (PDF; 414k)
http://www.bt.cdc.gov/agent/anthrax/LevelAProtocol/anthraxlabprotocol.pdf
Continually updated procedures to identify or rule out the presence of B. anthracis from a clinical specimen
Anthrax--Laboratory Techniques and Procedures--Process Assessment
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Evaluation
360
Centers for Disease Control and Prevention
"Specimen Collection of Smallpox (Vaccinia) Vaccine Virus : Information for lab workers" [Guidelines/protocol], 2003-01-06 (PDF; 126k)
http://www.bt.cdc.gov/agent/smallpox/vaccination/pdf/vaccinia-specimen-collection.pdf
A brief factsheet of guidelines for handing smallpox specimens in a laboratory setting
Smallpox--Vaccines--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
230
Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Review
Richmond, Jonathan Y. "Laboratory security and emergency response guidance for laboratories working with select agents" [Guidelines/protocol], 2002-12-06 (PDF; 152k)
http://www.cdc.gov/mmwr/PDF/RR/RR5119.pdf
Discussion of 1999 CDC guidelines and recommends conducting facility risk assessments and developing comprehensive security
plans to minimize the probability of misuse of select agents
Laboratory Techniques and Procedures--Security Measures--Process Assessment
CDC Focus Area :
Disaster Phase: Response/Recovery
231
Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Review
Witt-Kushner, Joyce. "Core function and capabilities of state public health laboratories : report of the Association of Public Health Laboratories" [Report (administrative)], 2002-09-20 (PDF; 206k)
http://www.cdc.gov/mmwr/PDF/RR/RR5114.pdf
Report of committee's analysis of needed core competencies of lab. Staff
Laboratory Techniques and Procedures--Education and Training
CDC Focus Area :
Disaster Phase: Planning
521
Centers for Disease Control and Prevention
"Comprehensive Procedures for Collecting Environmental Samples for Culturing Bacillus anthracis" [Guidelines/protocol], 2002-04-25 (PDF; 339k)
http://www.bt.cdc.gov/agent/anthrax/environmental-sampling-apr2002.pdf
Guidelines for environmental sampling to determine the presence of Bacillus anthracis spores in indoor environments
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area :
Disaster Phase: Evaluation
584
Centers for Disease Control and Prevention
Hoffmaster, Alex R. "Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak
in the United States" [Webcast], 2002-03-26 (ms powerPoint; 295k)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/hoffmaster.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Discusses the methodologies used in 2001 outbreak to suptype B. anthracis (pagA sequencing
and multi-locus variable (MLVA))
Anthrax--Laboratory Techniques and Procedures--Epidemiology
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
587
Centers for Disease Control and Prevention
Greene, Carolyn M. "Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak : October-December, 2001" [Webcast], 2002-03-26 (ms powerPoint; 79k)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/greene.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Discusses the use of an adaptation of the Serologic Assay during the 2001 Anthrax outbreak.
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
579
Centers for Disease Control and Prevention
Pettit, Denise. "Laboratory Response in the Commonwealth of Virginia to the Intentional Release of Bacillus anthracis" [Webcast], 2002-03-25 (MS PowerPoint; 1.23m)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/pettit.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Summary of the Laboratory Response Network and its response to the 2001 Anthrax incidents.
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
580
Centers for Disease Control and Prevention
Mayo, Donald. "Public Health Laboratory Response to an Anthrax Incident in Connecticut" [Webcast], 2002-03-25 (MS PowerPoint; 303k)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/mayo.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Summary of the laboratory sampling done in response to the 2001 Antrhax incidents and a
list of 'what worked' in lab protocols.
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
581
Centers for Disease Control and Prevention
Musser, Kimberlee. "Rapid Molecular Identification of B. anthracis in New York State in Response to Recent Bioterrorism Incidents" [Webcast], 2002-03-25 (ms powerPoint; 450k)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/musser.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Summary of the NYS - DOH response to increase demands on laboratories made by the 2001 Anthrax
incidents
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
582
Centers for Disease Control and Prevention
Kishore, Kamal. "Threat Letter Menace : The Fiji Experience" [Webcast], 2002-03-25 (ms powerPoint; 615k)
http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/kishore.pdf
Originally delivered as part of the AHRQ web-assisted teleconference, "Bioterrorism and Health System Preparedness:Emerging
Tools, Methods, and Strategies." Summary of the lab protocols established to deal with potential Anthrax spores on letters
in Fiji
Anthrax--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
332
Centers for Disease Control and Prevention
Laboratory Response Network, . "Level A Laboratory Procedures for Identification of Yersinia pestis" [Guidelines/protocol], 2001-12-13 (PDF; 293k)
http://www.bt.cdc.gov/Agent/Plague/ype_la_cp_121301.pdf
Guidelines includes information on acceptable samples, handling of samples, tests and results, and reporting protocols
Plague--Laboratory Techniques and Procedures--Awareness
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
373
Centers for Disease Control and Prevention
Laboratory Response Network, . "Level A Laboratory Procedures for Identification of Francisella tularensis" [Guidelines/protocol], 2001-12-13 (PDF; 202k)
http://www.bt.cdc.gov/Agent/Tularemia/ftu_la_cp_121301.pdf
Laboratory guidelines to rule out the presence of F. tularensis from a clinical specimen
Tularemia--Laboratory Techniques and Procedures--Awareness
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
432
Centers for Disease Control and Prevention
Laboratory Response Network, . "Level A Laboratory Procedures for Identification of Brucella Species" [Guidelines/protocol], 2001-12-12 (PDF; 330k)
http://www.bt.cdc.gov/Agent/Brucellosis/bsp_cla_cp_121201.pdf
Procedures to rule out Brucella in a laboratory sample
Brucellosis--Laboratory Techniques and Procedures--Education and Training
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Planning
476
United States Department of Health and Human Services
Lillibridge, Scott R. "Testimony [on Activities of the Department of Health and Human Services (HHS) in responding to Bioterrorism, other emergencies,
and acts of terrorism] : Before the Committee on Governmental Affairs, U.S Senate" [Speech/testimony], 2001-07-20 (HTML; 21k)
http://www.hhs.gov/asl/testify/t010720.html
Describes HHS's unified preparedness and response system to handle bioterrorist events as well as other threats
Bioterrorism--Preparedness--Federal Government
CDC Focus Area A: Preparedness Planning and Readiness Assessment
Disaster Phase: Planning
316
Centers for Disease Control and Prevention
"Clinical Aspects of Critical Biological Agents" [Presentations and conference papers], 1999-06-23 (MS PowerPoint; 4.22m)
http://www.bt.cdc.gov/documents/PPTResponse/1
One of four presentations in the Response to Bioterrorism series that were originally given as a training program for clinical
laboratory staff who may first encounter a potential bioterrorism agent. This presentation provides an overview to all Category
A agents
Bioterrorism--Diagnosis--Treatment
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Planning
317
Centers for Disease Control and Prevention
"Laboratory Response Network for Bioterrorism" [Presentations and conference papers], 1999-06-23 (MS PowerPoint; 267k)
http://www.bt.cdc.gov/documents/PPTResponse/phlab_ff_edits_99.ppt
One of four presentations in the Response to Bioterrorism series that were originally given as a training program for clinical
laboratory staff who may first encounter a potential bioterrorism agent. This presentation provides an overview of CDC's
LRN system
Bioterrorism--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Planning
325
Centers for Disease Control and Prevention
"Agents of Bioterrorism" [Presentations and conference papers], 1999-06-23 (PDF; 1.41m)
http://www.bt.cdc.gov/documents/PPTResponse/agentsglenfinal.pdf
One of four presentations in the Response to Bioterrorism series that were originally given as a training program for clinical
laboratory staff who may first encounter a potential bioterrorism agent. This presentation defines level A laboratory procedures
and gives basic information on all Category A agents
Bioterrorism--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Response/Recovery
514
Centers for Disease Control and Prevention
"Bioterrorism : an overview" [Presentations and conference papers], 1999-06-23 (MS PowerPoint; 2.46m)
http://www.bt.cdc.gov/documents/PPTResponse/laboverview.ppt
One of four presentations in the Response to Bioterrorism series that were originally given as a training program for clinical
laboratory staff who may first encounter a potential bioterrorism agent. This presentation provided a brief background on
Bioterrorism, the medical and public health response and the role of laboratory preparedness and the Laboratory Response Network
Bioterrorism--Preparedness--Laboratory Techniques and Procedures
CDC Focus Area C: Laboratory Capacity—Biologic Agents
Disaster Phase: Planning
333
Centers for Disease Control and Prevention
"Packaging Protocols for Biological Agents/Diseases" [Guidelines/protocol], (PDF; 52.7k)
http://www.bt.cdc.gov/labissues/PackagingInfo.pdf
Provides general triple packaging procedure and links to sites with Hazmat transportation regulations
Bioterrorism--Transportation--Laboratory Techniques and Procedures
CDC Focus Area :
Disaster Phase: Response/Recovery
|